You are here

Biblio

Search

Show only items where

Author

Type

Term

Year

Keyword

Export 2139 results:

] Title Type Year

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

B

Barzilay JI, Bůžková P, Fink HA, Cauley JA, Robbins JA, Garimella PS, Jalal DI, Mukamal KJ. Systemic markers of microvascular disease and bone mineral density in older adults : The cardiovascular health study. Osteoporos Int. 2016 ;27(11):3217-3225.

Barzilay JI, Bůzková P, Zieman SJ, Kizer JR, Djoussé L, Ix JH, Tracy RP, Siscovick DS, Cauley JA, Mukamal KJ. Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health Study. J Bone Miner Res. 2014 ;29(5):1061-6.

Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, Tracy RP, Klein R, Herrington DM. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. Am J Kidney Dis. 2004 ;44(1):25-34.

Barzilay JI, Forsberg C, Heckbert SR, Cushman M, Newman AB. The association of markers of inflammation with weight change in older adults: the Cardiovascular Health Study. Int J Obes (Lond). 2006 ;30(9):1362-7.

Barzilay JI, Tressel W, Biggs ML, Stein PK, Kizer JR, Shitole SG, Bene-Alhasan Y, Mukamal KJ. The Association of Measures of Cardiovascular Autonomic Function, Heart Rate, and Orthostatic Hypotension With Incident Glucose Disorders: The Cardiovascular Health Study. Diabetes Care. 2022 ;45(10):2376-2382.

Barzilay JI, Spiekerman CF, Wahl PW, Kuller LH, Cushman M, Furberg CD, Dobs A, Polak JF, Savage PJ. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet. 1999 ;354(9179):622-5.

Barzilay JI, Mukamal KJ, Kizer JR. Atherosclerotic cardiovascular disease in older adults with diabetes mellitus. Clin Geriatr Med. 2015 ;31(1):29-39, vii.

Barzilay JI, Blaum C, Moore T, Xue QLi, Hirsch CH, Walston JD, Fried LP. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med. 2007 ;167(7):635-41.

Barzilay JI, Fitzpatrick AL, Luchsinger J, Yasar S, Bernick C, Jenny NS, Kuller LH. Albuminuria and dementia in the elderly: a community study. Am J Kidney Dis. 2008 ;52(2):216-26.

Barzilay JI, Bůžková P, Djoussé L, Ix J, Kizer J, Cauley J, Matthan N, Lichtenstein AH, Mukamal KJ. Serum non-esterified fatty acid levels and hip fracture risk: The Cardiovascular Health Study. Osteoporos Int. 2021 .

Barzilay JI, Bůžková P, Chen Z, de Boer IH, Carbone L, Rassouli NN, Fink HA, Robbins JA. Albuminuria is associated with hip fracture risk in older adults: the cardiovascular health study. Osteoporos Int. 2013 ;24(12):2993-3000.

Barzilay JI, Bůzková P, Cauley JA, Robbins JA, Fink HA, Mukamal KJ. The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults. Osteoporos Int [Internet]. 2018 ;29(10):2230. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30132027

Barzilay JI, Bůzková P, Fink HA, Cauley JA, Carbone L, Elam R, Robbins JA, Stein P, Sheets K, Jalal D, et al. The associations of markers of endothelial dysfunction with hip fracture risk. Arch Osteoporos. 2023 ;18(1):39.

Barzilay JI, Bůžková P, Kizer JR, Djoussé L, Ix JH, Fink HA, Siscovick DS, Cauley JA, Mukamal KJ. Fibrosis markers, hip fracture risk, and bone density in older adults. Osteoporos Int. 2016 ;27(2):815-20.

Barzilay JI, Bůzková P, Kuller LH, Cauley JA, Fink HA, Sheets K, Robbins JA, Carbone LD, Elam RE, Mukamal KJ. The Association of Lipids and Lipoproteins with Hip Fracture Risk the Cardiovascular Health Study. Am J Med. 2022 .

Barzilay JI, Kronmal RA, Gottdiener JS, Smith NL, Burke GL, Tracy R, Savage PJ, Carlson M. The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study. J Am Coll Cardiol. 2004 ;43(12):2236-41.

Barnes DE, Haight TJ, Mehta KM, Carlson MC, Kuller LH, Tager IB. Secondhand smoke, vascular disease, and dementia incidence: findings from the cardiovascular health cognition study. Am J Epidemiol. 2010 ;171(3):292-302.

Barnes DE, Beiser AS, Lee A, Langa KM, Koyama A, Preis SR, Neuhaus J, McCammon RJ, Yaffe K, Seshadri S, et al. Development and validation of a brief dementia screening indicator for primary care. Alzheimers Dement. 2014 ;10(6):656-665.e1.

Barnes DE, Covinsky KE, Whitmer RA, Kuller LH, Lopez OL, Yaffe K. Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology. 2009 ;73(3):173-9.

Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry. 2006 ;63(3):273-9.

Barnes DE, Covinsky KE, Whitmer RA, Kuller LH, Lopez OL, Yaffe K. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Dementia risk indices: A framework for identifying individuals with a high dementia risk. Alzheimers Dement. 2010 ;6(2):138-41.

Barinas-Mitchell E, Kuller LH, Pietropaolo S, Zhang Y-J, Henderson T, Pietropaolo M. The prevalence of the 65-kilodalton isoform of glutamic acid decarboxylase autoantibodies by glucose tolerance status in elderly patients from the cardiovascular health study. J Clin Endocrinol Metab. 2006 ;91(8):2871-7.

Barfield R, Wang H, Liu Y, Brody JA, Swenson B, Li R, Bartz TM, Sotoodehnia N, Chen Y-derI, Cade BE, et al. Epigenome-wide association analysis of daytime sleepiness in the Multi-Ethnic Study of Atherosclerosis reveals African-American-specific associations. Sleep. 2019 .

Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, Nambi V, Bretler M, Smith NL, Peters A, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet. 2010 ;19(9):1863-72.

Barasch E, Gottdiener J, Bůzková P, Cappola A, Shah S, DeFilippi C, Gardin J, Kizer JR. Association of thyroid dysfunction in individuals ≥ 65 years of age with subclinical cardiac abnormalities. J Clin Endocrinol Metab. 2024 .

Pages